92 related articles for article (PubMed ID: 6327591)
21. Identification of pentadecapeptide mimicking muramyl peptide.
Laman AG; Shepelyakovskaya AO; Berezin IA; Boziev KM; Rodionov IL; Chulina IA; Malakhova GV; Brovko FA; Murashev AN; Korpela TK; Nesmeyanov VA
Vaccine; 2007 Apr; 25(15):2900-6. PubMed ID: 17005302
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
Alexandrou EN; Liakopoulou-Kyriakides M
Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of enzyme inhibition data in screening for new drugs.
Bush K
Drugs Exp Clin Res; 1986; 12(6-7):565-76. PubMed ID: 3488892
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic preparation of an immunostimulant, the disaccharide-dipeptide, N-acetyl-beta-D-glucosaminyl-(1----4)-N-acetylmuramyl-L-alanyl-D-is ogl utamine, from a bacterial peptidoglycan.
Guinand M; Francon A; Vacheron MJ; Michel G
Eur J Biochem; 1984 Sep; 143(2):359-62. PubMed ID: 6381058
[TBL] [Abstract][Full Text] [Related]
25. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
26. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
Merhi G; Coleman AW; Devissaguet JP; Barratt GM
J Med Chem; 1996 Oct; 39(22):4483-8. PubMed ID: 8893843
[TBL] [Abstract][Full Text] [Related]
28. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
[TBL] [Abstract][Full Text] [Related]
29. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of a peptidoglycan recognition protein (PGRP) in complex with a muramyl tripeptide from Gram-positive bacteria.
Guan R; Roychowdury A; Ember B; Kumar S; Boons GJ; Mariuzza RA
J Endotoxin Res; 2005; 11(1):41-6. PubMed ID: 15826377
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
Iribe H; Koga T
Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
[TBL] [Abstract][Full Text] [Related]
32. Design of peptide derived amino alcohols as transition-state analog inhibitors of angiotensin converting enzyme.
Gordon EM; Godfrey JD; Pluscec J; Von Langen D; Natarajan S
Biochem Biophys Res Commun; 1985 Jan; 126(1):419-26. PubMed ID: 2982376
[TBL] [Abstract][Full Text] [Related]
33. K-13, a novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia. II. Structure determination.
Yasuzawa T; Shirahata K; Sano H
J Antibiot (Tokyo); 1987 Apr; 40(4):455-8. PubMed ID: 3034845
[TBL] [Abstract][Full Text] [Related]
34. Sleep factor, muramyl peptides, and the serotoninergic system.
Masek K; Kadlec O
Lancet; 1983 Jun; 1(8336):1277. PubMed ID: 6134066
[No Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors: synthesis and structure-activity relationships of potent N-benzyloxycarbonyl tripeptide inhibitors.
Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Yamamoto R; Deguchi T; Takeyama K; Hosoki K
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2417-22. PubMed ID: 2605684
[TBL] [Abstract][Full Text] [Related]
36. "Meshed-Bag Gathered-Bunch" method for solid-phase synthesis of small molecular diverse compounds.
Zhang SD; Liu G; Xia SQ; Wu P; Zhang L
J Comb Chem; 2002; 4(2):131-7. PubMed ID: 11886287
[TBL] [Abstract][Full Text] [Related]
37. Structure elucidation of angiotensin converting enzyme inhibitor L-681,176 from Streptomyces sp. MA 5143a.
Hensens OD; Liesch JM
J Antibiot (Tokyo); 1984 May; 37(5):466-8. PubMed ID: 6203887
[TBL] [Abstract][Full Text] [Related]
38. Sleep factors: do muramyl peptides activate serotonin binding sites?
Root-Bernstein RS; Westall FC
Lancet; 1983 Mar; 1(8325):653. PubMed ID: 6131333
[No Abstract] [Full Text] [Related]
39. Bayliss-Starling Memorial Lecture (1982). Induction of sleep by muramyl peptides.
Pappenheimer JR
J Physiol; 1983 Mar; 336():1-11. PubMed ID: 6875901
[No Abstract] [Full Text] [Related]
40. Secretion of macrophage cytotoxic factors induced by new desmuramyl acylpseudopeptide analogs of muramyl dipeptide.
Breton P; Petit C; Bousser MT; Monsigny M; Mayer R; Roche AC
Oncol Res; 1992; 4(3):103-7. PubMed ID: 1617210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
